Upexi (NASDAQ:UPXI) Lowered to “Sell” Rating by Wall Street Zen

Wall Street Zen lowered shares of Upexi (NASDAQ:UPXI) from a hold rating to a sell rating in a research report released on Saturday morning.

Several other equities analysts also recently issued reports on the stock. Weiss Ratings reissued a “sell (d)” rating on shares of Upexi in a report on Monday, December 29th. Cantor Fitzgerald reduced their target price on shares of Upexi from $16.00 to $6.00 and set an “overweight” rating for the company in a research note on Friday, November 14th. Two equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $10.50.

Upexi Stock Performance

Shares of UPXI stock opened at $1.91 on Friday. The company has a market cap of $120.73 million, a P/E ratio of -0.45 and a beta of -0.48. The business has a 50 day moving average of $2.77 and a two-hundred day moving average of $4.94. Upexi has a 52 week low of $1.67 and a 52 week high of $22.57. The company has a quick ratio of 3.39, a current ratio of 3.41 and a debt-to-equity ratio of 0.68.

Upexi (NASDAQ:UPXI) last announced its quarterly earnings results on Wednesday, November 12th. The company reported ($0.12) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.11). Upexi had a negative return on equity of 30.42% and a net margin of 264.25%.The company had revenue of $9.24 million for the quarter, compared to analyst estimates of $7.33 million.

Upexi announced that its board has approved a share repurchase program on Thursday, November 13th that authorizes the company to buyback $50.00 million in outstanding shares. This buyback authorization authorizes the company to repurchase up to 25.1% of its stock through open market purchases. Stock buyback programs are often a sign that the company’s management believes its shares are undervalued.

Insider Activity at Upexi

In related news, CEO Allan Marshall acquired 100,000 shares of the stock in a transaction that occurred on Monday, December 15th. The shares were acquired at an average price of $2.07 per share, for a total transaction of $207,000.00. Following the completion of the purchase, the chief executive officer directly owned 3,946,261 shares of the company’s stock, valued at $8,168,760.27. The trade was a 2.60% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Gene Salkind bought 100,000 shares of the company’s stock in a transaction that occurred on Monday, November 17th. The shares were purchased at an average cost of $2.65 per share, for a total transaction of $265,000.00. Following the acquisition, the director owned 569,470 shares of the company’s stock, valued at $1,509,095.50. This represents a 21.30% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders bought 350,000 shares of company stock valued at $793,000 over the last quarter. Insiders own 4.42% of the company’s stock.

Institutional Trading of Upexi

Several institutional investors have recently modified their holdings of UPXI. Kathmere Capital Management LLC bought a new stake in shares of Upexi in the 2nd quarter worth approximately $6,535,000. NewGen Equity Long Short Fund bought a new stake in Upexi during the second quarter worth approximately $1,720,000. NewGen Asset Management Ltd acquired a new position in Upexi in the second quarter worth approximately $1,720,000. Millington Financial Advisors LLC bought a new position in shares of Upexi in the second quarter valued at $60,000. Finally, North Star Investment Management Corp. acquired a new stake in shares of Upexi during the 2nd quarter valued at $45,000. Institutional investors and hedge funds own 5.68% of the company’s stock.

About Upexi

Upexi (NASDAQ: UPXI) is a full-service digital consultancy that partners with brands to design, develop, and deploy digital products and marketing strategies. The company’s expertise spans user experience and interface design, custom software engineering, and data-driven marketing services. By integrating research, creative design, and technical execution, Upexi helps clients accelerate product development cycles and optimize their digital presence.

The firm serves a diverse, global clientele across sectors such as e-commerce, software-as-a-service (SaaS), healthcare, and finance.